Systemic mastocytosis with associated hematologic neoplasm (SM-AHN) presents unique diagnostic and treatment challenges. In this Medscape-certified activity, experts discuss the complex patient journey, from delayed diagnosis to individualized…
Avapritinib, branded as Ayvakit, became the first FDA-approved treatment for indolent systemic mastocytosis (ISM) in 2023, marking a major advancement for patients. ISM, driven by the KIT D816V…
NEW YORK (Reuters Health) – When radical cystectomy is not performed within 12 weeks of diagnosis with stage II bladder cancer, all-cause and disease-specific mortality increases, US researchers…
Jaime Landman MD, Director of Minimally Invasive Urology at Columbia Medical Center discusses Cytoreductive Nephrectomy, the cutting edge of kidney cancer management for patients whose disease is not…
NEW YORK (Reuters Health) – Men ages 75 to 80 years old with a prostate specific antigen (PSA) level less than 3 ng/mL are unlikely to experience life-threatening…
NEW YORK (Reuters Health) – In older prostate cancer patients with a biochemical recurrence, cancer anxiety predicts earlier use of androgen deprivation therapy (ADT), new research shows. This…
NEW YORK (Reuters Health) – Although it is safe, low-dose vitamin K used to treat warfarin recipients with high INRs (international normalized ratios) does not reduce episodes of…
NEW YORK (Reuters Health) – New evidence indicates that elevated serum levels of ionized calcium may predict the risk of death from prostate cancer. If verified in future…
NEW YORK (Reuters Health) – In a phase I trial involving patients with advanced squamous cell carcinoma of the head and neck (SCCHN), direct intratumoral injection of epithelial…
NEW YORK (Reuters Health) – Patients with rectal cancer whose disease is downstaged with neoadjuvant radiation therapy have better survival than their peers who fail to respond to…
NEW YORK (Reuters Health) – Yearly gynecological examinations fail to identify early stage ovarian cancer in women with a mutation in the BRCA1 or BRCA2 gene, a Dutch…
NEW YORK (Reuters Health) – New research suggests that B-cell clones may be a useful early marker for chronic lymphocytic leukemia (CLL) since they are found in nearly…
